Alamar Biosciences, Inc. (California) (ALMR)
34.36
+1.90
(+5.85%)
USD |
NASDAQ |
Oct 02, 16:00
34.62
+0.26
(+0.76%)
Pre-Market: 20:00
Alamar Biosciences Profit Margin (Quarterly) : -44.85% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.85% |
| March 31, 2026 | -81.91% |
| Date | Value |
|---|---|
| June 30, 2025 | -43.45% |
| March 31, 2025 | -58.51% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| 10X Genomics, Inc. | -11.87% |
| Personalis, Inc. | -141.7% |
| Adaptive Biotechnologies Corp. | -55.82% |
| Champions Oncology, Inc. | -2.80% |
| Medpace Holdings, Inc. | 17.16% |
Profit Margin (Quarterly) Related Metrics
| Gross Profit Margin (Quarterly) | 60.21% |
| Operating Margin (Quarterly) | -45.98% |